On October 1, 2021, we signed a joint research agreement with the Faculty of Pharmaceutical Sciences, Keio University on the early detection of cancer using liquid terahertz spectroscopic spectrometry technology, and jointly filed a patent application in January 2023. In order to continue our research, we agreed to extend the joint research agreement in March 2024.
